Testosterone and the male skeleton: a dual mode of action
- PMID: 21941679
- PMCID: PMC3173882
- DOI: 10.4061/2011/240328
Testosterone and the male skeleton: a dual mode of action
Abstract
Testosterone is an important hormone for both bone gain and maintenance in men. Hypogonadal men have accelerated bone turnover and increased fracture risk. In these men, administration of testosterone inhibits bone resorption and maintains bone mass. Testosterone, however, is converted into estradiol via aromatization in many tissues including male bone. The importance of estrogen receptor alpha activation as well of aromatization of androgens into estrogens was highlighted by a number of cases of men suffering from an inactivating mutation in the estrogen receptor alpha or in the aromatase enzyme. All these men typically had low bone mass, high bone turnover and open epiphyses. In line with these findings, cohort studies have confirmed that estradiol contributes to the maintenance of bone mass after reaching peak bone mass, with an association between estradiol and fractures in elderly men. Recent studies in knock-out mice have increased our understanding of the role of androgens and estrogens in different bone compartments. Estrogen receptor activation, but not androgen receptor activation, is involved in the regulation of male longitudinal appendicular skeletal growth in mice. Both the androgen and the estrogen receptor can independently mediate the cancellous bone-sparing effects of sex steroids in male mice. Selective KO studies of the androgen receptor in osteoblasts in male mice suggest that the osteoblast in the target cell for androgen receptor mediated maintenance of trabecular bone volume and coordination of bone matrix synthesis and mineralization. Taken together, both human and animal studies suggest that testosterone has a dual mode of action on different bone surfaces with involvement of both the androgen and estrogen receptor.
Figures
Similar articles
-
Androgens and bone.Endocr Rev. 2004 Jun;25(3):389-425. doi: 10.1210/er.2003-0003. Endocr Rev. 2004. PMID: 15180950 Review.
-
A concise review of testosterone and bone health.Clin Interv Aging. 2016 Sep 22;11:1317-1324. doi: 10.2147/CIA.S115472. eCollection 2016. Clin Interv Aging. 2016. PMID: 27703340 Free PMC article. Review.
-
Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.J Bone Miner Res. 2006 Apr;21(4):576-85. doi: 10.1359/jbmr.060103. Epub 2006 Apr 5. J Bone Miner Res. 2006. PMID: 16598378
-
Androgens and the skeleton.Minerva Endocrinol. 2005 Mar;30(1):15-25. Minerva Endocrinol. 2005. PMID: 15877010 Review.
-
Aromatase activity and bone homeostasis in men.J Clin Endocrinol Metab. 2004 Dec;89(12):5898-907. doi: 10.1210/jc.2004-1717. J Clin Endocrinol Metab. 2004. PMID: 15579733 Review.
Cited by
-
Effect of Day Length on Growth and Gonadal Development in Meishan Male Pigs.Animals (Basel). 2024 Mar 13;14(6):876. doi: 10.3390/ani14060876. Animals (Basel). 2024. PMID: 38539974 Free PMC article.
-
The importance of gravity vector on adult mammalian organisms: Effects of hypergravity on mouse testis.PLoS One. 2023 Sep 29;18(9):e0282625. doi: 10.1371/journal.pone.0282625. eCollection 2023. PLoS One. 2023. PMID: 37773950 Free PMC article.
-
Skeletal effects following developmental flame-retardant exposure are specific to sex and chemical class in the adult Wistar rat.Front Toxicol. 2023 Jul 27;5:1216388. doi: 10.3389/ftox.2023.1216388. eCollection 2023. Front Toxicol. 2023. PMID: 37577032 Free PMC article.
-
Relationship between Body Mass Index and Bone Turnover Markers in Girls with Idiopathic Central Precocious Puberty.Int J Clin Pract. 2023 Apr 28;2023:6615789. doi: 10.1155/2023/6615789. eCollection 2023. Int J Clin Pract. 2023. PMID: 37153692 Free PMC article.
-
Increased fat mass negatively influences femoral neck bone mineral density in men but not women.Front Endocrinol (Lausanne). 2023 Feb 28;14:1035588. doi: 10.3389/fendo.2023.1035588. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36926024 Free PMC article.
References
-
- Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocrine Reviews. 2004;25(3):389–425. - PubMed
-
- Lanfranco F, Zirilli L, Baldi M, et al. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone. 2008;43(3):628–635. - PubMed
-
- Zirilli L, Rochira V, Diazzi C, Caffagni G, Carani C. Human models of aromatase deficiency. Journal of Steroid Biochemistry and Molecular Biology. 2008;109(3–5):212–218. - PubMed
-
- Bouillon R, Bex M, Vanderschueren D, Boonen S. Estrogens are essential for male pubertal periosteal bone expansion. Journal of Clinical Endocrinology and Metabolism. 2004;89(12):6025–6029. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
